Thyroid disease in progressive systemic sclerosis Patología tiroídea en la esclerosis sistémica progresiv a.
Author
dc.contributor.author
Besançon,
Author
dc.contributor.author
Guzmán Guzmán, Iris P
Author
dc.contributor.author
Grisanti,
Author
dc.contributor.author
Basualdo,
Author
dc.contributor.author
Alvarado Alvarado, José Luis
Author
dc.contributor.author
Rendic,
Author
dc.contributor.author
Pineda,
Admission date
dc.date.accessioned
2019-01-29T14:49:22Z
Available date
dc.date.available
2019-01-29T14:49:22Z
Publication date
dc.date.issued
1990
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 118, Issue 4, 2018, Pages 388-391
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160833
Abstract
dc.description.abstract
There is no agreement wither thyroid disease is a common feature of progressive systemic sclerosis (PSS). We evaluated 28 patients with proven PSS with determinations of T3, T4, TSH and Tg as well as antimicrosomal autoantibodies. Radioactive I uptake, thyroid scintigraphy, TRH test and fine needle biopsy were performed in selected patients. Twelve (43%) patients had clinical or laboratory evidence of thyroid dysfunction. Four patients had euthyroid goiter, 3 had evidence of autoimmune disease, 2 had chronic Hashimoto's thyroiditis, 1 was hypothyroid, 1 hyperthyroid and one has subacute thyroiditis. The CREST variant of PSS was most commonly associated with thyroid pathology. Our results indicated that thyroid disease is frequently associated to PSS. A complete clinical and laboratory evaluation is needed to confirm its presence.